Appeal No. 2000-1780 Application No. 08/403,663 Appeal No. 1999-0399 Application No. 08/377,503 Claim 140 is illustrative of the subject matter on appeal41 and is reproduced below: 1. An isolated polynucleotide that codes for a kainate-binding human EAA5 receptor, wherein said receptor is: the human EAA5a receptor having the amino acid sequence of residues 1-888 of SEQ ID NO:2; the human EAA5b receptor having the amino acid sequence of residues 1-888 of SEQ ID NO:2 except that residue 321 is arginine; or the human EAA5c receptor having the amino acid sequence of residues 1-838 of SEQ ID NO:2 followed by Pro-Pro. Claim 10 is limited to a recombinant DNA construct, wherein said construct is plasmid pcDNAI/humEAA5a (ATCC 75296). Claim 17 is limited to a membrane preparation derived from a cell transfected with a heterologous DNA that encodes for EAA5a, EAA5b or EAA5c as described in claim 1 with the exception that the EAA5c receptor instead of followed by two proline residues instead of the specific “Pro-Pro” sequence of defined in claim 1. 40 Claim 1 was amended after final (Paper No. 36, received July 14, 1997). The above reproduction of claim 1 includes this amendment. 41 We note the examiner’s clarification (Answer, page 4) of applicants’ Appendix of appealed claims wherein the examiner states that “line 2 of claim 10, “7” should be replaced with “9”. 39Page: Previous 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 NextLast modified: November 3, 2007